Q

uniQure NV

D
QURE
USD
0.26
(3.6212%)
Market Closed
34,632.00
Volume
-4.23
EPS
-
Div Yield
-1.256757
P/E
362,310,285.36
Market Cap
Today
3.6212%
1 Week
29.843%
1 Month
39.587%
6 Months
54.357%
12 Months
8.140%
Year To Date
9.815%
All Time
0%

Title:
uniQure NV

Sector:
Healthcare
Industry:
Biotechnology
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Do you need help or have a question?